Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: Profile and risk factors

Journal of Sexual Medicine

Volumn 12, Issue 3, 2015, Pages 713-719

  Anele, Uzoma A ^a   Burnett, Arthur L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Epidemiology; Erection; Penis

Indexed keywords

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; INTERNATIONAL INDEX OF ERECTILE FUNCTION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIAPISM; PRIORITY JOURNAL; RECURRENT ISCHEMIC PRIAPISM; RETROSPECTIVE STUDY; RISK FACTOR; SICKLE CELL ANEMIA; TOBACCO USE; ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; COMPARATIVE STUDY; COMPLICATION; FACTUAL DATABASE; ISCHEMIA; MARYLAND; MEDICAL RECORD; ODDS RATIO; PATHOPHYSIOLOGY; PENIS; PSYCHOLOGY; QUESTIONNAIRE; RECURRENT DISEASE; VASCULARIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BALTIMORE; CHILD; DATABASES, FACTUAL; ERECTILE DYSFUNCTION; HUMANS; ISCHEMIA; MALE; MEDICAL RECORDS; ODDS RATIO; PENIS; PREVALENCE; PRIAPISM; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84924025724     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12816     Document Type: Article

References (32)

1. Berger R, Billups K, Brock G, Broderick GA, Dhabuwala CB, Goldstein I, Hakim LS, Hellstrom W, Honig S, Levine LA, Lue T, Munarriz R, Montague DK, Mulcahy JJ, Nehra A, Rogers ZR, Rosen R, Seftel AD, Shabsigh R, Steers W, Evaluation ATLPo, Treatment of P. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impot Res 2001;13(5 suppl):S39-43.
2. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID. American Urological Association guideline on the management of priapism. J Urol 2003;170:1318-1324.
3. Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980;140:1434-1437.
4. Kovac JR, Mak SK, Garcia MM, Lue TF. A pathophysiology-based approach to the management of early priapism. Asian J Androl 2013;15:20-26.
5. Broderick GA. Priapism and sickle-cell anemia: Diagnosis and nonsurgical therapy. J Sex Med 2012;9:88-103.
6. Ralph DJ, Garaffa G, Muneer A, Freeman A, Rees R, Christopher AN, Minhas S. The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur Urol 2009;56:1033-1038.
7. Rees RW, Kalsi J, Minhas S, Peters J, Kell P, Ralph DJ. The management of low-flow priapism with the immediate insertion of a penile prosthesis. BJU Int 2002;90:893-897.
8. Adeyoju AB, Olujohungbe AB, Morris J, Yardumian A, Bareford D, Akenova A, Akinyanju O, Cinkotai K, O'Reilly PH. Priapism in sickle-cell disease; incidence, risk factors and complications-An international multicentre study. BJU Int 2002;90:898-902.
9. Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol 1986;135:142-147.
10. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med 2006;3:1077-1084.
11. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346-351.
12. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-326.
13. Mulhall JP, Bivalacqua TJ, Becher EF. Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy. J Sex Med 2013;10:195-203.
14. Teloken P, Valenzuela R, Parker M, Mulhall J. The correlation between erectile function and patient satisfaction. J Sex Med 2007;4:472-476.
15. Garcia FJ, Violette PD, Brock GB, Pautler SE. Predictive factors for return of erectile function in robotic radical prostatectomy: Case series from a single centre. Int J Impot Res 2014. doi: 10.1038/ijir.2014.20.
16. El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: Risk factors for erectile dysfunction. BJU Int 2002;89:285-290.
17. Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A 2005;102:1661-1666.
18. Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL. New insights into the pathophysiology of sickle cell disease-associated priapism. J Sex Med 2012;9:79-87.
19. Bivalacqua TJ, Burnett AL. Priapism: New concepts in the pathophysiology and new treatment strategies. Curr Urol Rep 2006;7:497-502.
20. Bivalacqua TJ, Ross AE, Strong TD, Gebska MA, Musicki B, Champion HC, Burnett AL. Attenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell mice. Urology 2010;76:e7-12.
21. Yuan J, Desouza R, Westney OL, Wang R. Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian J Androl 2008;10:88-101.
22. Akinsheye I, Klings ES. Sickle cell anemia and vascular dysfunction: The nitric oxide connection. J Cell Physiol 2010;224:620-625.
23. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002;8:1383-1389.
24. Kanika ND, Melman A, Davies KP. Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue. Int J Impot Res 2010;22:363-373.
25. Lagoda G, Sezen SF, Cabrini MR, Musicki B, Burnett AL. Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis. J Urol 2013;189:762-768.
26. Lagoda G, Sezen SF, Hurt KJ, Cabrini MR, Mohanty DK, Burnett AL. Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism. FASEB J 2014;28:76-84.
27. Munarriz R, Park K, Huang YH, Saenz de Tejada I, Moreland RB, Goldstein I, Traish AM. Reperfusion of ischemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism. Urology 2003;62:760-764.
28. Wood KC, Granger DN. Sickle cell disease: Role of reactive oxygen and nitrogen metabolites. Clin Exp Pharmacol Physiol 2007;34:926-932.
29. Bivalacqua TJ, Musicki B, Hsu LL, Berkowitz DE, Champion HC, Burnett AL. Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress. PLoS ONE 2013;8:e68028.
30. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology 2006;67:1043-1048.
31. Burnett AL, Anele UA, Trueheart IN, Strouse JJ, Casella JF. Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease. Am J Med 2014;127:664-668.
32. Bennett N, Mulhall J. Sickle cell disease status and outcomes of African-American men presenting with priapism. J Sex Med 2008;5:1244-1250.